AstraZeneca’s global consolidation drives data insights, savings and traveler satisfaction


The U.K.-based pharmaceutical giant wanted to stop fragmented travel management. The goal was a global, end-to-end program.


The travel team partnered with us on a consolidation and change-management strategy that brought together 70 countries in just 7 months to simplify processes, improve insights, boost traveler experiences and cut costs.


AstraZeneca achieved:

  • 15% savings on managed travel spend in one year
  • 95% of managed travel spend rolled into consolidated data
  • 100% visibility into trips booked through BCD Travel
  • 86% traveler satisfaction

“We needed comprehensive, consolidated data to understand where out-of-policy spend was happening and then make improvements,” said Kerrie Henshaw-Cox, AstraZeneca’s travel program leader. “Our consolidated travel program enables the travel team to better support AstraZeneca business leaders.”

New on